151 related articles for article (PubMed ID: 18667635)
1. Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.
Fu C; Liang J; Wang M
Clin Vaccine Immunol; 2008 Sep; 15(9):1425-8. PubMed ID: 18667635
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of live attenuated S79 mumps vaccine effectiveness in mumps outbreaks: a matched case-control study.
Fu CX; Nie J; Liang JH; Wang M
Chin Med J (Engl); 2009 Feb; 122(3):307-10. PubMed ID: 19236809
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
Liang Y; Che Y; Yang B; Zhan F; Li H; Guan X; Zhang Y; Yin Q; Li C; Li J; Zhao Z; Liu L; Jiang G; Liao Y; Xu X; Ye J; Ren Q; He Y; Feng M; Wang L; Fan S; Cui X; Wang Z; Li C; Xiao H; Liu R; Li Q; Jiang C; Liu J; Li Q
J Infect Dis; 2019 Jan; 219(1):50-58. PubMed ID: 30085178
[TBL] [Abstract][Full Text] [Related]
4. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine.
Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S
Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214
[TBL] [Abstract][Full Text] [Related]
5. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.
Ma C; Liu Y; Tang J; Jia H; Qin W; Su Y; Wang H; Hao L
Hum Vaccin Immunother; 2018 Jun; 14(6):1392-1397. PubMed ID: 29377772
[TBL] [Abstract][Full Text] [Related]
6. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
7. Nasal antibody response to mumps virus after vaccination and natural infection.
Tanaka K; Baba K; Okada S; Okuno Y; Yamanishi K; Ueda S; Takahashi M; Yamada A
Vaccine; 1992; 10(12):824-7. PubMed ID: 1455908
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of mumps in preschool institutions using a live mumps vaccine made from strain L-3].
Garaseferian MG; Bolotovskiĭ VM; Shatrova LP; Titova NS
Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):39-42. PubMed ID: 2970740
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
[TBL] [Abstract][Full Text] [Related]
10. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of one dose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006-2012.
Fu C; Xu J; Cai Y; He Q; Zhang C; Chen J; Dong Z; Hu W; Wang H; Zhu W; Wang M
Hum Vaccin Immunother; 2013 Dec; 9(12):2524-8. PubMed ID: 23955378
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a live attenuated mumps vaccine: a phase I clinical trial.
Liang Y; Ma J; Li C; Chen Y; Liu L; Liao Y; Zhang Y; Jiang L; Wang XY; Che Y; Deng W; Li H; Cui X; Ma N; Ding D; Xie Z; Cui P; Ji Q; Wang J; Zhao Y; Wang J; Li Q
Hum Vaccin Immunother; 2014; 10(5):1382-90. PubMed ID: 24614759
[TBL] [Abstract][Full Text] [Related]
13. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation.
Pittet LF; Verolet CM; McLin VA; Wildhaber BE; Rodriguez M; Cherpillod P; Kaiser L; Siegrist CA; Posfay-Barbe KM
Am J Transplant; 2019 Mar; 19(3):844-854. PubMed ID: 30171797
[TBL] [Abstract][Full Text] [Related]
14. Identification and development of a promising novel mumps vaccine candidate strain.
Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
[TBL] [Abstract][Full Text] [Related]
15. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
[TBL] [Abstract][Full Text] [Related]
16. [An outbreak of mumps in a high school: Estimation of vaccine effectiveness. Zaragoza 2011].
Compés-Dea C; Guimbao-Bescós J; Gaspar-Escayola JI; Lázaro-Belanche MÁ; Aznar-Brieba A
Enferm Infecc Microbiol Clin; 2015; 33(6):385-90. PubMed ID: 25475656
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to mumps virus proteins in natural mumps infection and after vaccination with live and inactivated mumps virus vaccines.
Julkunen I; Väänänen P; Penttinen K
J Med Virol; 1984; 14(3):209-19. PubMed ID: 6389772
[TBL] [Abstract][Full Text] [Related]
18. [Mumps outbreak in the Plzeň Region in 2011].
Pazdiora P; Skálová J; Kubátová A; Ježová I; Morávková I; Podlesná I; Průchová J; Spáčilová M; Švecová M
Epidemiol Mikrobiol Imunol; 2015 Oct; 64(4):242-9. PubMed ID: 26795229
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of school children with live mumps virus vaccine.
Furesz J; Nagler FP
Can Med Assoc J; 1970 May; 102(11):1153-5. PubMed ID: 5420994
[TBL] [Abstract][Full Text] [Related]
20. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
